الصفحة الرئيسية>>TXNIP-IN-1

TXNIP-IN-1

رقم الكتالوجGC61362

TXNIP-IN-1 هو مثبط مركب TXNIP-TRX (بروتين متفاعل مع ثيوريدوكسين) مستخرج من براءة الاختراع US20200085800A1 ، المركب 1

Products are for research use only. Not for human use. We do not sell to patients.

TXNIP-IN-1 التركيب الكيميائي

Cas No.: 1268955-50-5

الحجم السعر المخزون الكميّة
5mg
315٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

TXNIP-IN-1 is TXNIP-TRX (thioredoxin-interacting protein- thioredoxin) complex inhibitor extracted from patent US20200085800A1, Compound 1. TXNIP-IN-1 can be used in the research of TXNIP-TRX complex associated metabolic disorder (diabetes), cardiovascular disease, or inflammatory disease[1].

TXNIP-IN-1 bocks high glucose (HG induced) TXNIP-TRX complex formation[1].TXNIP-IN-1 (1.25-5 μM) reduces HG-induced expression of TNF in monocytes[1].TXNIP-IN-1 (1.25-5 μM; 72 hours) inhibits TXNIP mRNA expression in THP1 cells[1].TXNIP-IN-1 (0.3-10 μM; 72 hours) inhibits TXNIP mRNA expression in murine RAW macrophages[1].TXNIP-IN-1 (5-20 μM; 72 hours) decreases TXNIP but not TNF-alpha mRNA levels in MIN6 cells[1].TXNIP-IN-1 (0.62-5 μM; 72 hours) affects TXNIP and TNF-alpha mRNA expression in human pancreas 1.1B4 beta cells[1].TXNIP-IN-1 (5 μM; 16-72 hours) inhibits c-TRX interaction in THP1 cells cultured in 25mM glucose[1].TXNIP-IN-1 targets TXNIP mRNA in human pancreatic islets[1].

[1]. Rama Natarajan, et al. Txnip-trx complex inhibitors and methods of using the same. US20200085800A1.

مراجعات

Review for TXNIP-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for TXNIP-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.